CVE-2023-50946

CVE-2023-50946 is a medium-severity vulnerability in Ibm Common Licensing with a CVSS 3.x base score of 6.5. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-863.

Key facts

Description

IBM Common Licensing 9.0 could allow an authenticated user to modify a configuration file that they should not have access to due to a broken authorization mechanism.

Frequently asked questions

What is CVE-2023-50946?
IBM Common Licensing 9.0 could allow an authenticated user to modify a configuration file that they should not have access to due to a broken authorization mechanism.
How severe is CVE-2023-50946?
CVE-2023-50946 has a CVSS 3.x base score of 6.5, rated medium severity. It is exploitable over network with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is none, integrity high, and availability none.
Is CVE-2023-50946 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (18th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2023-50946?
CVE-2023-50946 affects Ibm Common Licensing. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2023-50946?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
Does CVE-2023-50946 have an EU (EUVD) identifier?
Yes. CVE-2023-50946 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2023-55675.
When was CVE-2023-50946 published?
CVE-2023-50946 was published on 2025-01-26 and last updated on 2026-06-17.

References

Affected products (1)

More vulnerabilities in Ibm Common Licensing

All CVEs affecting Ibm Common Licensing →

Other CWE-863 (Incorrect Authorization) vulnerabilities

Browse all CWE-863 (Incorrect Authorization) vulnerabilities →